Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Food and Drug Administration Staff; Food and Drug Administration Decisions for Investigational Device Exemption Clinical Investigations; Availability
Health and Human Services Department, Food and Drug Administration
What is this?
This is a regulatory record from Health and Human Services Department, Food and Drug Administration — a rule, proposed rule, or notice. Regulations carry the force of law once final, and often invite public comment before that point.
Why does it matter?
Regulations are usually what actually binds you, more than statutes are. This is where an agency states the requirement, the effective date, and whether there is still a window to respond.
Key Details
- Posted Date
- NAICS Code
- 621999
- Source
- Federal Register
- Contract Type
- regulation
Description
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled "FDA Decisions for Investigational Device Exemption (IDE) Clinical Investigations." This guidance document has been developed to promote the initiation of clinical investigations to evaluate medical devices under FDA's IDE regulations. In an effort to promote timely clinical investigations in a manner that protects study subjects, FDA has developed methods to allow a clinical investigation to begin under certain circumstances, even when there are outstanding issues regarding the IDE submission. These mechanisms, including approval with conditions, staged approval or staged approval with conditions, and communication of outstanding issues related to the IDE through future considerations, are described in this guidance.
Frequently Asked Questions
Does this regulation apply to me?+
Follow This Regulation
Follow this regulation in Bureauify to see changes as they are published.
Intelligence
- Win probability analysis
- Competitive landscape
- Incumbent analysis
- Price-to-win estimate
- Similar awards history